MassIVE MSV000095459

Partial Public

Branched-chain amino acid catabolism promotes ovarian cancer cell proliferation via phosphorylation of mTOR

Description

Slides were placed in a humidified incubator at 37C and 5% CO2 and cocultured for 4 days. After 4 days, the 8-well chamber was detached from the glass slide, and omental tissue was removed with a razor blade prior to desiccation. Agarose cocultures were desiccated on the ITO-glass slide in an incubator at 30C on a home-built spinning apparatus for 4 hours. (Lusk JASMS 2022) MALDI matrices alpha-cyano-4-hydroxycinnamic acid (CHCA (98%), C2020, Sigma-Adlrich) and 2,5-dihydroxybenzoic acid (DHB (98%), 149357, Sigma-Aldrich) were recrystallized in-house as previously described. The MALDI matrix used for MSI was a 50:50 mixture of CHCA:DHB at 10 mg/mL dissolved in 90:10 ACN:H2O with 0.1% TFA applied using a TM sprayer (HTX Imaging). Before MSI analysis, slides were scanned using Tissue Scout (Bruker Daltonics) for the initial screen and Epson Perfection V850 Pro for subsequent experiments. Scanned images were used to guide irradiation. MSI data was acquired using timsControl v2.0.51.0_9669_1571 and flexImaging 5.1 software for the initial screen, fleximaging 7.4 for subsequent experiments at 100 micron spatial resolution on a timsTOF fleX mass spectrometer (Bruker Daltonics). Data were collected using a mass range of 50-1500 Da in positive ion mode with the laser width set to 100 micron imaging and the laser power set to 90%. At each raster point, 1,000 laser shots were delivered at a frequency of 1,000 Hz. The instrument was calibrated manually using phosphorus red prior to imaging. MSI data was analyzed, and statistical analysis was performed using SCiLS Lab version 2023c core (Bruker Daltonics). All spectra were normalized to the root mean square (RMS). [doi:10.25345/C5WS8HZ09] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: metabolomics ; mass spectrometry imaging ; 3D cell culture ; ovarian cancer

Contact

Principal Investigators:
(in alphabetical order)
Laura Sanchez, University of California Santa Cruz, USA
Submitting User: l2sanchez
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

- Dataset Reanalyses


+ Dataset History


Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.